Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA's Orphan Drug Program Update Looking At Similarity Standard

This article was originally published in The Pink Sheet Daily

Executive Summary

EMA can't approve a similar product during an orphan drug's 10-year exclusivity period, but some criteria for that determination have not been officially defined.